Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
|08 Mar 2021||$0.4850||100.00%||Interim||31 Mar 2021|
|05 Mar 2020||$0.6250||100.00%||Interim||27 Mar 2020|
|05 Sep 2019||$0.9150||100.00%||Final||30 Sep 2019|
|06 Mar 2019||$0.6000||100.00%||Interim||29 Mar 2019|
|05 Sep 2018||$0.8650||100.00%||Final||28 Sep 2018|
|06 Mar 2018||$0.5750||100.00%||Interim||29 Mar 2018|
|05 Sep 2017||$0.8150||100.00%||Final||28 Sep 2017|
|07 Mar 2017||$0.5300||100.00%||Interim||29 Mar 2017|
|06 Sep 2016||$0.7200||100.00%||Final||29 Sep 2016|
|08 Mar 2016||$0.4700||100.00%||Interim||30 Mar 2016|
|04 Sep 2015||$0.6050||100.00%||24 Sep 2015|
|05 Mar 2015||$0.4050||100.00%||26 Mar 2015|
|08 Sep 2014||$0.5100||100.00%||Final||24 Sep 2014|
|04 Mar 2014||$0.3400||100.00%||Interim||26 Mar 2014|
|03 Sep 2013||$0.4150||100.00%||Final||25 Sep 2013|
|04 Mar 2013||$0.2900||100.00%||Interim||27 Mar 2013|
|05 Mar 2012||$0.2550||100.00%||Interim||28 Mar 2012|
|02 Sep 2011||$0.2950||100.00%||Final||26 Sep 2011|
|08 Mar 2011||$0.2250||100.00%||Interim||28 Mar 2011|
|31 Aug 2010||$0.2500||100.00%||Final||27 Sep 2010|
|16 Mar 2010||$0.1850||100.00%||Interim||09 Apr 2010|
|21 Sep 2009||$0.2150||100.00%||Final||09 Oct 2009|
|20 Mar 2009||$0.1650||100.00%||Interim||08 Apr 2009|
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
Ramsay Health Care Limited (RHC) is a global healthcare company that operates 221 hospitals and 14 day surgery centres, treatment facilities, rehabilitation and psychiatric units and a nursing college across Australia, United Kingdom, France, Indonesia, Malaysia and Italy.
Established in Sydney, Australia, in 1964, Ramsay Health Care has more than 50 years of experience in providing acute health care services. RHC made its ASX debut in 1997 and the Ramsay share price has gone from strength to strength since.
Today, Ramsay employs more than 77,000 staff and delivers a range of acute and primary healthcare services from 480 facilities across 11 countries, making it one of the largest and most diverse private healthcare companies in the world.
|23 Jul 2021||$64.64||$0.25||0.39%||256,065||$64.19||$64.77||$64.11|
|22 Jul 2021||$64.39||$0.13||0.20%||1,570,001||$64.42||$64.68||$63.64|
|21 Jul 2021||$64.26||$0.29||0.45%||982,551||$64.36||$65.36||$64.02|
|20 Jul 2021||$63.97||$0.43||0.68%||624,227||$63.48||$64.35||$62.99|
|19 Jul 2021||$63.54||$0.44||0.70%||257,522||$62.97||$63.64||$62.70|
|16 Jul 2021||$63.10||$0.00||0.00%||867,014||$63.10||$63.28||$62.77|
|15 Jul 2021||$63.10||$-0.79||-1.24%||555,523||$64.06||$64.15||$63.02|
|14 Jul 2021||$63.89||$0.39||0.61%||577,057||$63.62||$63.98||$63.48|
|13 Jul 2021||$63.50||$0.49||0.78%||922,265||$63.08||$63.71||$62.89|
|12 Jul 2021||$63.01||$-0.25||-0.40%||349,652||$63.57||$63.71||$62.58|
|09 Jul 2021||$63.26||$-1.12||-1.74%||579,972||$64.01||$64.14||$62.87|
|08 Jul 2021||$64.38||$0.84||1.32%||663,245||$63.75||$64.84||$63.75|
|07 Jul 2021||$63.54||$0.64||1.02%||466,410||$63.29||$64.15||$63.10|
|06 Jul 2021||$62.90||$-0.17||-0.27%||480,632||$63.25||$63.98||$62.81|
|05 Jul 2021||$63.07||$0.24||0.38%||819,928||$62.90||$63.82||$62.80|
|02 Jul 2021||$62.83||$0.03||0.05%||372,283||$63.14||$63.36||$62.71|
|01 Jul 2021||$62.80||$-0.15||-0.24%||431,474||$63.17||$63.25||$62.60|
|30 Jun 2021||$62.95||$-0.09||-0.14%||505,314||$63.50||$63.85||$62.88|
|29 Jun 2021||$63.04||$-0.54||-0.85%||393,496||$63.22||$63.36||$62.74|
|28 Jun 2021||$63.58||$-0.39||-0.61%||346,864||$63.95||$64.02||$63.29|
|25 Jun 2021||$63.97||$0.37||0.58%||352,894||$64.39||$64.60||$63.76|
|15 Dec 2020||Craig McNally||Expiry||48||$3,060,191||
As advised by the company. 196,371 - Performance Rights
|15 Dec 2020||Craig McNally||Issued||55||$3,522,694||
Issue of securities. 244,639 - Performance Rights
|Mr Peter John Evans||Non-Executive DirectorNon-Executive Deputy Chairman||Dec 1990||
Mr Evans began working with Ramsay Health Care in 1969. He is a Chartered Accountant who was in public practice for over 20 years with predecessor firms of KPMG. Mr Evans has specialised in the financial management of hospitals and has had experience in the health care field for 50 years. Mr Evans is also a Trustee of the Paul Ramsay Foundation and has been involved with several other charitable organisations over many years. He is member of Risk Management committee.
|Mr David Ingle Thodey||Non-Executive Director||Nov 2017||
Mr Thodey is a business leader who has had a executive career in the technology and telecommunications industries, with more than 30 years of experience creating brand and shareholder value. In addition to being a Non-Executive Director and Lead Independent Director of Ramsay Health Care, Mr Thodey is currently Chairman of Australia's national scientific research agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Chairman of Tyro Payments Limited (a leading alternative payments provider) and Xero Limited (a small business accounting software company). Mr Thodey also had a successful career as CEO of Telstra, Australia's leading telecommunications and information services company, and prior to that he was CEO of IBM. Mr Thodey was awarded an Order of Australia in 2017 for his service to business and the promotion of ethical leadership and workplace diversity. In the past three years, Mr Thodey has served as a Director of the following listed companies: Xero Limited (Appointed June 2019), Tyro Payments Limited (Appointed November 2018) and Vodafone Group Plc (Resigned July 2020). He is chairman of Governance Committee and member of People Committee.
|Ms Catriona Alison Deans||Non-Executive Director||Nov 2018||
Ms Deans has 25 years experience building technology-enabled businesses involved in media, ecommerce, financial services and health, and across leadership roles as an executive, a director and in venture capital. Ms Deans joined the Board of Ramsay Health Care in November 2018. She is also a Non-Executive Director of Westpac Banking Corporation, Cochlear Limited, SCEGGS Darlinghurst and Deputy Pty Ltd. She is also on the Investment Committee of MainSequence Ventures. In her executive career Ms Deans was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited, (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas, and most recently CEO of netus Pty Ltd - a technology investment company acquired by Fairfax. Ms Deans also spent seven years as a Consultant with McKinsey & Company and is currently a Senior Advisor with the firm. In the past three years, Ms Deans has served as a Director of the following listed companies: Cochlear Limited (Appointed February 2015), Westpac Banking Corporation (Appointed April 2014) and Insurance Australia Group Limited (Resigned October 2017). She is member of People Committee and Governance Committee.
|Mr Michael Stanley Siddle||Non-Executive DirectorNon-Executive Chairman||May 1975||
Mr Siddle has experience in the management of private hospitals and has been integrally involved in Ramsay Health Care's successful expansion through construction, mergers and acquisitions. Mr Siddle is also a Trustee of the Paul Ramsay Foundation. He is member of People and Governance committee.
|Mr Craig Ralph McNally||Chief Executive OfficerManaging Director||Jul 2017||
Mr McNally was an executive of a private hospital in Sydney following completion of a health administration degree at the University of New South Wales.
|Ms Karen Lee Collett Penrose||Non-Executive Director||Mar 2020||
Ms Penrose has had an executive career in leadership and CFO roles, mainly in financial services. She is well-versed in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. Ms Penrose also serves as a Director of Vicinity Centres, Bank of Queensland, and Estia Health. Ms Penrose is a member of Chief Executive Women and on the Board of Marshall Investments Pty Limited. In the past three years, Ms Penrose has served as a Director of the following listed companies: Vicinity Centres (Appointed June 2015), Bank of Queensland (Appointed November 2015), Estia Health (Appointed October 2018), Spark Infrastructure Group (Resigned May 2020), Future Generation Global Investment Company Limited (Resigned October 2018) and AWE Limited (Resigned April 2018). She is member of Risk Management Committee.
|Ms Claudia Ricarda Rita Sussmuth Dyckerhoff||Non-Executive Director||Oct 2018||
Dr Dyckerhoff has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and was transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, Dr Dyckerhoff transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She also led McKinsey's Asia-wide Health Systems and Services Sector. Dr Dyckerhoff also supports three start-ups, and in September 2017 she joined the Board of med tech start-up Cyrcadia. In the past three years, Dr Sussmuth Dyckerhoff has served as a Director of the following listed companies: Hoffmann La Roche (Appointed March 2016) and Clariant AG (Appointed April 2016). She is member of Risk Management Committee
|Mr James Malcolm McMurdo||Non-Executive Director||Sep 2019||
Mr McMurdo has over 30 years finance and banking experience. He has a background in corporate advisory spanning across mergers and acquisitions, strategic advisory and financing with experience across multiple industries including the healthcare sector. He has held senior operating management roles and worked in both the Asia Pacific and European regions. Until July 2020, Mr McMurdo was Vice Chairman of Investment Banking for Deutsche Bank based in Hong Kong. He has held senior management roles at Deutsche Bank including Global Co-Head of Corporate Finance, Head of Corporate and Investment Bank for Asia Pacific and CEO for Australia and New Zealand. He sat on the firm's Global Executive Committee for the Corporate and Investment Bank for four years. Prior to this, Mr McMurdo was a Partner at Goldman Sachs where he held senior positions in the Investment Banking Division in Australia and Europe.
|Ms Henrietta Rowe||Company SecretaryGroup General Counsel||Jun 2019||
|Daniel Sims||CEO Ramsay Australia||
|Henrietta Rowe||Company SecretaryGroup General Counsel||
|Martyn Roberts||Group Chief Financial Officer||
|Olivier Chretien||Group Chief Strategy Officer||
|Hsbc Custody Nominees (Australia) Limited||53,909,722||23.55%|
|Paul Ramsay Holdings Pty Limited||42,999,269||18.79%|
|J P Morgan Nominees Australia Pty Limited||33,404,461||14.59%|
|Citicorp Nominees Pty Limited||13,175,972||5.76%|
|National Nominees Limited||8,265,947||3.61%|
|BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C>||3,863,144||1.69%|
|Woolwich Investments Pty Ltd <The Siddle Family Trust>||3,750,000||1.64%|
|BNP Paribas Nominees Pty Ltd <DRP>||3,236,785||1.41%|
|Custodial Services Limited <Beneficiaries Holding A/C>||2,448,055||1.07%|
|Argo Investments Limited||2,023,131||0.88%|
|Australian Foundation Investment Company Limited||2,020,000||0.88%|
|Sargon Ct Pty Limited||2,010,406||0.88%|
|Netwealth Investments Limited <Wrap Services A/C>||1,083,872||0.47%|
|Citicorp Nominees Pty Limited <Colonial First State Inv A/C>||951,540||0.42%|
|HSBC Custody Nominees (Australia) Limited <NT Comnwlth Super Corp A/C>||899,255||0.39%|
|BNP Paribas Nominees Pty Ltd HUB24 Custodial Services Limited <DRP>||597,717||0.26%|
|BNP Paribas Nominees (NZ) Pty Ltd <DRP>||521,714||0.23%|
|Australian Executor Trustees Limited <IPS Super A/C>||513,494||0.22%|
|HSBC Custody Nominees (Australia) Limited i||473,717||0.21%|
|BKI Investment Company Limited||438,535||0.19%|